News

Harro Hofliger has introduced OmniControl, which is a modular checking system for maximum flexibility with the weighing of solida. The company said that OmniControl is the format-free checking

Conceptus has reported that the US District Court, Northern District of California has denied Conceptus’ motion for a preliminary injunction prohibiting Hologic, from importing, using, selling or offering

The FDA has approved Istodax (romidepsin), an injectable medication, for treatment of patients with cutaneous T-cell lymphoma (CTCL). Istodax interferes with processes required for cell replication. It is

The acquisition of the manufacturing license will be effected through the acquisition of equity in Tianda as well as transfer of certain technologies from Tianda. Rosuvastatin was first

Huya Bioscience (Huya) has entered into a strategic partnership with the School of Medicine and Pharmacy, Ocean University of China. The agreement is an addition in a series

GlaxoSmithKline (GSK) has reported the results from the clinical trial assessing Pandemrix. GSK’s adjuvanted H1N1 pandemic influenza vaccine, Pandemrix is administered at the same time as the annual

Genmab has initiated a Phase III study of Arzerra ofatumumab plus chemotherapy versus rituximab plus chemotherapy to treat patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

Concert Pharmaceuticals has initiated a Phase 1b clinical study with CTP-518, investigational oral HIV protease inhibitor for the treatment of HIV infection. In connection with the start of

Zosano Pharma has revealed results from a positive Phase 2 study of its rapid-delivery transdermal patch (ZP-PTH) for the treatment of postmenopausal osteoporosis. The results were published in